SureTrader
Interactive Brokers Advertisement
Home > Boards > Canadian > Biotechs >

Algae Dynamics (ADYNF)

ADYNF RSS Feed
Add ADYNF Price Alert      Hide Sticky   Hide Intro
Moderator: NetworkNewsWire
Search This Board: 
Last Post: 11/16/2017 1:14:21 PM - Followers: 4 - Board type: Free - Posts Today: 0

Algae Dynamics Corp (ADYNF) is focused on the development of proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company's product development strategy is the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

Leading Algae Dynamics' initiatives is a management team with nearly a century of combined beneficial experience, including management and process experience, fund raising, and commercialization. The company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. With this strong foundation, Algae Dynamics is well-positioned to execute on its plan to build a revenue-generating, sustainable opportunity in a rapidly expanding market.

Investment Highlights

  • Focused on the development of the unique, combined health benefits of cannabis and algae oil
    Capitalizing on the under-served cannabis licensed producer marketplace in Canada
    Canadian oil extraction marketplace forecast to reach $1.7 billion in the year 2020
    Operations in Canada avoid exposure to federal regulation of cannabis in the United Sates
    Strong R&D collaboration with leading universities with oil extraction expertise

 


Business Strategy

Developing unique health and nutraceutical products using cannabis, hemp and algae oils

Because of the many demonstrated health benefits of botanical oils, Algae Dynamics has developed a strategy to develop products that combine the health benefits specifically from algae, hemp and cannabis oils. The company is leveraging its algae oil expertise into the cannabis oil extraction marketplace, positioned to capitalize on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption. This expertise, along with collaborations with the University of Waterloo and the University of Western Ontario, serves as catalysts for ongoing initiatives to create and market research-driven product formulations.

The company's growth initiatives include plans to:

  • Leverage algae oil extraction expertise into cannabis oil extraction marketplace
    Research benefits of combining certain algae and cannabis oils for enhanced effects
    Leverage university collaborations to create specific cannabis oil product lines
    Retain the rights of all patents developed in collaboration with universities
    Apply for oil extraction and Licensed Producer license (retail sales and distribution)
    Position the company for medical and recreational markets (domestic & export)
    Develop product branding, as well as develop sales channels in compliance with Canadian regulations

 


R&D Collaborations

Using university-level research to create specific cannabis oil product lines

 

UNIVERSITY OF WATERLOO

Dr. Jonathan Blay, PhD, FRSB, FIBMS, Csci, CBiol
Professor of Pharmacy, University of Waterloo
Professor of Pathology, Dalhousie University

Dr. Blay's research group applies a range of techniques in molecular and cellular biology to understand cell behavior and how the action of existing anticancer drugs are affected by the unique physiology of the cancer. The goal is to perform fundamental cancer-related research on botanical oils and their constituents which will carry out studies relating to the cellular safety and known cancer-related potential of components within the oils.

 

UNIVERSITY OF WESTERN ONTARIO

Dr. Steven Laviolette, BSc, PhD
Addiction Research Group
Dept. of Anatomy & Cell Biology. Dept. of Psychiatry
Canadian Institute for Military and Veterans Health Research

Dr. Laviolette's investigations have focused on nicotine and opiates, highly addictive substances that act on pathways in the brain that control reward, motivation and learning. His research group has characterized and identified specific regions in the mammalian brain that control the 'switch' from the non-addicted state, to the addicted state following exposure to drugs of abuse. The goal of his research is to determine how specific cannabis-derived phytochemical compounds such as delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD) and other phytochemical and/or terpenoid compounds derived from cannabis, may serve to ameliorate symptoms and/or serve as potential pharmacotherapies for schizophrenia, anxiety, depression and post-traumatic stress disorder.

 

Algae Dynamics will retain the rights of all patents developed in collaboration with universities.

 


 

Algae & Cannabis Oils

Cannabis by itself has long been used for medical purposes, and in recent decades has gained significant traction in becoming a common and preferred treatment for specific ailments. Algae Dynamics' strategic initiative will also explore compounds extracted from other botanicals, most notably cannabis, and to seek product development and formulation opportunities that combine the benefits of algae and cannabis oils. The above two programs bring Algae Dynamics total university research commitment to $1. 6 million.

Algae Oil
  • Supports endocannabinoid system
    Improves memory
    Lowers risk of coronary heart disease and improvement in cholesterol
    Supports results from studies in cancer treatment, depression and attention-deficit hyperactivity disorder (ADHD)
  • Need a better understanding of basic neural processes involved in the modulation of the pharmacological properties of drugs
    Need to investigate chemicals found naturally in the human body that mimic those in marijuana in controlling nausea, vomiting, learning, memory and protection against stroke and cancer
    The research cuts across the science of: Psychology, Pharmacology and Neurobiology
Algae Oil

The following are some of the health benefits of algae and cannabis that the Company intends to research further to potentially combine into synergistic products:

Algae Omega-3 Cannabis
Detoxes heavy metals and toxins Reduces stress and anxiety
Supports immune system Reduces glaucoma and prevents macular degeneration
Fights cancer Prevents certain cancers
Detoxifies radiation and chemotherapy Relives pain
Lowers cholesterol and blood glucose levels Increases appetite
Improves cardiovascular function Stimulates antioxidant processes
Improves cognitive functioning Fights multiple sclerosis and schizophrenia
Fights Alzheimer's disease Fights neurodegenerative disorders
Reduces antiplatelet effects Reduces migraines and headaches
Reduces major coronary events Fights epilepsy
Acts as an anti-inflammatory agent Fights obesity and metabolic syndrome
Improves memory Fights anorexia and osteoporosis

 


 

Development Activities

 


 

Canadian Cannabis Market

The under-served market for licensed producers in Canada offers great opportunity for Algae Dynamics. Currently there are only 50 licensed producers in all of Canada, which has a population of 35 million – roughly the size of California. For perspective, in Colorado there are now 624 licensed cultivators.

The Canadian oil extraction marketplace is forecast to grow from C$1 million in 2015 to C$1.5 billion in 2020, assuming full legalization in 2019, according to Mackie Research Capital Corp.

In terms of conversion from dried marijuana to extracts/oil, due diligence has been conducted on Colorado market, finding that 45% of dried marijuana users would eventually convert to marijuana extracts/oil. Algae Dynamics expects the Canadian market to follow a similar trend as Colorado, and anticipates that the market will gradually reach an approximate 45% conversion rate by 2018.

Full Legalization in 2018

  CY2015E
Dec31/2015
CY2016E
Dec31 2016
CY2017E
Dec31 2017
CY2018E
Dec31/2018
CY2019E
Dec31 2019
CY2020E
Dec31 2020
Dried marijuana (C$, 'M) $48 $93 $185 $431 $784 $1,113
Extracts/oil (C$, 'M) $1 $33 $132 $755 $1,367 $1,687
Total Market Size (C$, "M) $49 $126 $316 $1,186 $2,151 $2,800
% Change   160% 150% 275% 81% 30%

Full Legalization in 2019

  CY2015E
Dec31/2015
CY2016E
Dec31 2016
CY2017E
Dec31 2017
CY2018E
Dec31/2018
CY2019E
Dec31 2019
CY2020E
Dec31 2020
Dried marijuana (C$, 'M) $48 $93 $185 $309 $666 $952
Extracts/oil (C$, 'M) $1 $33 $132 $258 $1,102 $1,535
Total Market Size (C$, "M) $49 $126 $316 $567 $1,769 $2,487
% Change   160% 150% 79% 212% 41%

Full Legalization in 2020

  CY2015E
Dec31/2015
CY2016E
Dec31 2016
CY2017E
Dec31 2017
CY2018E
Dec31/2018
CY2019E
Dec31 2019
CY2020E
Dec31 2020
Dried marijuana (C$, 'M) $48 $93 $185 $309 $499 $842
Extracts/oil (C$, 'M) $1 $33 $132 $258 $412 $1,205
Total Market Size (C$, "M) $49 $126 $316 $567 $911 $2,047
% Change   160% 150% 79% 60% 125%

 


 

Marketing Strategies

Advertising and marketing of medical marijuana in Canada is regulated by the Food and Drugs Act (Canada) and the Narcotic Control Regulations issued under the Controlled Drugs and Substances Act (Canada). Licensed Producers are strictly prohibited from advertising marijuana products or promoting their use.

Algae Dynamics' marketing activities will be focused on the promotion of the company and increasing its visibility within the marketplace. Those efforts will include working with numerous client education centers (patient aggregators), which will review the available research data provided by the universities on medical cannabis oils and products available to clients. Algae Dynamics believes this scientific data will help clients make educated decisions.

Algae Dynamics believes it will have significant advantages in the market that will include multiple strain selection and consistently-produced cannabis oil products backed by scientific research that supports the improved effectiveness of each treatment.

Algae Dynamics is actively preparing to respond to increased market demand that is expected to occur following the coming into force of proposed legislation to legalize and regulate recreational marijuana. It intends to participate fully in the legalized recreational marijuana marketplace, subject to compliance with applicable regulatory requirements.

 


Management

As part of strategy to be the No. 1 research Canadian cannabis oil research-driven product formulator, Algae Dynamics relies on the leadership of an experience management team, which is supported by a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives.

EXECUTIVE LEADERSHIP

Richard Rusiniak (Mechanical Engineer) - Co-Founder & CEO

  • More than 30 years of management, design and process experience
    Co-founder and former president, CFO and CTO of Cymat Corp (TSX: CYM) with a market valuation over $150 million upon his resignation in 2002
    Negotiated an Aluminum Foam Manufacturing license with Alcan International Ltd.; successfully commercialized the technology
    Completed a $10 million technology development program with Industry Canada (TPC)
    Participated in the completion of $25 million in financing with financial institutions

Paul Ramsay (BBA) - Co-Founder & President

  • Over 25 years of business development and management experience
    Co-founder and former CEO and VP Business Development of Cymat Corp, (TSX: CYM) with a market valuation over $150 million upon his resignation in 2002
    Instrumental in securing the Stabilized Aluminum Foam (SAF) license from Alcan International Ltd.
    Completed a $10 million technology development program with Industry Canada (TPC)
    Participated in the completion of $25 million in financing with financial institutions

Ross Eastley (CA) - CFO

  • Over 30 years of accounting and CFO experience in private and public sectors
    Former CEO for the Canadian Society of Immigration Consultants (CSIC)
    Responsible for strategic planning, corporate communications, initial regulatory functions and management of legal processes
    Former VP/Controller for Brandon University

ADVISORS

Dr. Kirsten Muller (PhD) - Lead Phycologist

  • Over 10 years of experience researching and cultivating algae
    Associate professor at the University of Waterloo and associate director of the Canadian Phycology Culture Centre (CPCC)
    Author of more than 25 papers in leading phycology journals
    Recipient of many national and international research awards
    Awarded the Luigi Provasoli Award in recognition of authoring the outstanding paper published in the Journal of Phycology (Phycological Society of America) during 2011

Dr. Brendan McConkey (PhD) - Algae Oil Analysis

  • Over seven years of research experience as associate professor at the University of Waterloo
    Areas of expertise include proteomics, biochemistry, toxicology and computational biology
    Research emphasis on interdisciplinary approaches that combine biology, chemical engineering and computational research

Dr. Terry H. Walker (PhD) - Bioprocess Advisor

  • Over 20 years of experience in biosystems engineering, food and bioprocess engineering, and biochemical engineering
    Professor at Clemson University in Biosystems and Environmental Engineering
    Author of 17 papers and obtained a patent and provisional patent for some of his projects
    Affiliated with the Institute of Biological Engineering (IBE); Society for Industrial Microbiologists (SIM), and Sigma Xi Scientific Research Society
    2006 recipient of the SCBio Reward for development of marine-based antibiotics

STRATEGIC ADVISORS

Graeme G. Phipps (B.Sc.) - Oil Industry Experience

  • Over 30 years of oil & gas operational and management experience with Exxon, CanOxy/Nexen and Petro Canada
    Executive VP of PetroKazakhstan (2005) and was preparing to become president and CEO when it was successfully sold for US$4.2 billion to China National Petroleum Corporation
    Director of several public and private international oil & gas companies
    Extensive experience with financial transactions and investment banking

Mark Goldberg (PhD in Pharmacology)

  • Over 25 years of experience in biomedical research and as a regulatory consultant.
    Currently serves on PlantForm Corporation's board of directors, a biopharma start-up that he founded
    Director of MedCannAccess and an entrepreneur in Residence at Innovation Guelph
    Joined the Department of Biomedical Sciences at the Ontario Veterinary College of the University of Guelph in 1982, and was a tenured faculty member until 1994
    Awarded the University of Guelph's Forster Fellowship in 1987
    Authored more than 50 scientific publications, primarily in the cancer research field
    Co-founder of GlobalTox International Consultants, a toxicology and regulatory affairs firm and serves as its president and CEO for 17 years
    Board-certified by the American Board of Toxicology
    Received the Chartered Directors (C.Dir.) designation from The Directors College

 


Algae Dynamics
4120 Ridgeway Dr., Unit 37
Mississauga, ON
L5L 5S9 Canada
www.algaedynamics.com

NetworkNewsWire
1324 Lexington Ave. Suite 117
New York, NY 10128
Phone: (212) 418-1217
www.NetworkNewsWire.com

 

NetworkNewsWire is a moderator of this board. Please see disclaimer on the NetworkNewsWire website: https://www.networknewswire.com/disclaimer/

SureTrader
Interactive Brokers Advertisement
ADYNF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ADYNF News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/15/2017 12:16:16 PM
ADYNF News: Current Report Filing (8-k) 11/09/2017 09:56:58 AM
ADYNF News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/15/2017 04:50:11 PM
ADYNF News: Annual Report (10-k) 08/15/2017 06:07:48 AM
ADYNF News: Notification That Annual Report Will Be Submitted Late (nt 10-k) 06/30/2017 12:43:21 PM
PostSubject
#69   ADYNF Receives Grant from Mitacs for Cannabis Research Collaboration NetworkNewsWire 11/16/17 01:14:21 PM
#68   ADYNF Receives $250,000 Investment to Enhance Existing University NetworkNewsWire 11/15/17 11:34:10 AM
#67   ADYNF Continues Collaborative Research on Safer Cannabinoid Delivery NetworkNewsWire 11/01/17 12:35:23 PM
#66   Canada’s Cannabis Market Presents Big Potential for ADYNF NetworkNewsWire 10/19/17 12:37:45 PM
#65   ADYNF Sees Opportunity for Hemp, Algae, and CBD NetworkNewsWire 10/13/17 01:05:34 PM
#64   ADYNF Takes the Safe Road in Cannabis Delivery NetworkNewsWire 10/06/17 01:45:59 PM
#63   ADYNF Prepares for Increased Cannabis Demand in Canada NetworkNewsWire 10/06/17 12:00:05 PM
#62   ADYNF Research Efforts Focus on Healthier Benefits of NetworkNewsWire 10/02/17 12:29:55 PM
#61   ADYNF Collaborative Study Yields Possible Breakthrough in Reversing NetworkNewsWire 09/29/17 03:10:00 PM
#60   ADYNF Collaborates with University of Western Ontario NetworkNewsWire 09/21/17 04:16:51 PM
#59   ADYNF Collaborates with Prominent Neuroscientist to Research Cannabinoid NetworkNewsWire 09/15/17 12:40:30 PM
#58   ADYNF Collaborating with Prominent Neuroscientist to Research Benefits NetworkNewsWire 09/12/17 04:04:37 PM
#57   ADYNF Focuses on Cannabis Oil Vision for Medicinal Applications NetworkNewsWire 09/06/17 01:49:06 PM
#56   ADYNF Profiting within Niche Cannabis Market NetworkNewsWire 09/01/17 12:14:43 PM
#55   ADYNF Exploiting a Profitable Niche in Canada’s Booming NetworkNewsWire 08/30/17 12:21:59 PM
#54   ADYNF Positioned to Benefit as Market Survey Highlights NetworkNewsWire 08/28/17 04:10:14 PM
#53   ADYNF Poised to Profit from Impending Recreational Cannabis Legalization NetworkNewsWire 08/25/17 12:10:45 PM
#52   ADYNF Creating a Lucrative Niche Opportunity NetworkNewsWire 08/16/17 01:54:26 PM
#51   ADYNF Announces Entry into Letter of Intent with NetworkNewsWire 08/16/17 09:51:14 AM
#50   ADYNF Hoping US Senate Bill Decriminalizing Marijuana Will NetworkNewsWire 08/10/17 10:57:38 AM
#49   ADYNF Targets Smokeless Medical Cannabis Market, Partners with NetworkNewsWire 08/02/17 12:39:51 PM
#48   ADYNF Developing Potential Breakthrough Fortified Formulas to Boost NetworkNewsWire 07/28/17 12:24:20 PM
#47   ADYNF Therapeutic Fortified Formulas Likely to Boost Endocannabinoid System NetworkNewsWire 07/26/17 03:20:33 PM
#46   Wow, $ADYNF up 76%. You are just full Cody6 07/25/17 02:35:54 PM
#45   ADYNF is Developing Therapies that Offer Safer Delivery NetworkNewsWire 07/18/17 02:20:20 PM
#44   ADYNF Featured in Exclusive Audio Interview by NetworkNewsWire NetworkNewsWire 07/18/17 12:22:20 PM
#43   ADYNF is Revolutionizing Plant-Based Therapeutics for a Range NetworkNewsWire 07/17/17 03:14:47 PM
#42   ADYNF Changing the Dynamic of Plant Based Therapeutics NetworkNewsWire 07/11/17 01:18:52 PM
#41   ADYNF Poised for Expansion into Canadian Cannabis Oil Market NetworkNewsWire 07/10/17 11:59:51 AM
#40   ADYNF Management at a Glance NetworkNewsWire 07/06/17 11:40:17 AM
#39   ADYNF Continues Cannabis Oil Research as Potential Marijuana NetworkNewsWire 06/29/17 11:32:20 AM
#38   ADYNF Targets Nutraceutical Market Leveraging Health and Efficacy NetworkNewsWire 06/28/17 12:22:00 PM
#37   ADYNF is “One to Watch” NetworkNewsWire 06/21/17 11:55:27 AM
#36   Nice bounce today. Does anyone know what's happening Cody6 04/19/17 10:44:59 AM
#35   Revised business strategy, now in the cannabis industry. Big Brother 03/29/17 03:36:25 PM
#34   Nice move today saj 04/22/16 04:05:08 PM
#33   Will keep my eye on this one as SoccerDad1973 03/31/16 03:09:33 PM
#32   Will definitely be keeping one eye on ADYNF zigzagman 03/24/16 01:54:25 PM
#31   As previously announced the Company has entered into zigzagman 03/23/16 04:10:55 PM
#30   There's a big demand for Chlorella in North zigzagman 03/22/16 04:04:37 PM
#29   So thin on the Ask... zigzagman 03/21/16 02:49:27 PM
#28   Another big volume day, with a nice bounce zigzagman 03/18/16 04:20:55 PM
#27   50K Volume today! zigzagman 03/17/16 03:42:46 PM
#26   Would like to see an update soon about zigzagman 03/16/16 03:17:50 PM
#25   Key milestones that position ADYNF for future development: zigzagman 03/15/16 01:24:46 PM
#24   yeah, I saw that and totally agree. SoccerDad1973 03/15/16 01:07:05 PM
#23   ADYNF announced that its S-1 Registration Statement filing zigzagman 03/14/16 03:22:10 PM
#22   Algae Dynamics will target two key segments of zigzagman 03/11/16 02:10:08 PM
#21   Volume is picking up a little bit!... zigzagman 03/10/16 02:38:43 PM
#20   Tiny Float here ~ Only 1.27 Million shares! zigzagman 03/09/16 02:43:58 PM
PostSubject